← Back to headlines
Attovia Biotech Aims to Halt Chronic Itch at its Source
Attovia, a clinical-stage biotech company, is developing treatments with the goal of stopping chronic itch by targeting its underlying causes.
17 Aug, 13:10 — 17 Aug, 13:10
Sources
Showing 1 of 1 sources
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
49m ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
8h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
10h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
19h ago